| Literature DB >> 32738651 |
Jinjin Shi1, Xue Yang1, Yanan Li1, Danyu Wang1, Wei Liu1, Zhenzhong Zhang1, Junjie Liu2, Kaixiang Zhang3.
Abstract
Nanoparticle-based CRISPR/Cas9 delivery systems hold great promise for specific and precise treatment of genetic disorder diseases. Herein, we developed a DNA nanoflower-based platform for microRNA-responsive cytosolic delivery of Cas9/sgRNA complex into tumor cells. The biocompatible DNA nano-vehicles can efficiently load Cas9/sgRNA by sequence hybridization. Importantly, this hybridization can be replaced by a tumor specific miRNA through toehold-mediated strand displacement process and achieve cell-type-specific release of Cas9/sgRNA from the DNA nanoflowers. We have verified that this miRNA-responsive releasing process can significantly improve the genome editing efficiency comparing with non-responsive control. This strategy suggests a versatile way for designing more specific and efficient CRISPR-based genome therapy system by incorporating stimuli-responsive Cas9/sgRNA release process.Entities:
Keywords: CRISPR/Cas9; DNA nanoflower; cytosolic delivery; genome editing; miRNA-responsive
Mesh:
Substances:
Year: 2020 PMID: 32738651 DOI: 10.1016/j.biomaterials.2020.120221
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479